Drug Development

Articles

Also, Genmab will acquire PDL Pharma's Minnesota manufacturing facility, DSM Pharmaceuticals appointed Hans Engels president and business unit director, more...

Company and People Notes: Akorn Enters Supply Agreement, Vernalis Makes Changes to Senior Management Positions, More

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

The US Patent and Trademark Office rejected the patentability of claims of a patent by Genentech that related to certain methods used to make antibodies and antibody fragments by recombinant DNA.

Genentech Loses Round in Patent Dispute

APP Pharmaceuticals will boost manufacturing of therapeutic multidose vials of heparin.

APP Increases Heparin Production to Avoid Shortage

Also, Biocon will acquire 70% of AxiCorp, ARIAD Pharmaceuticals promoted Richard W. Pascoe to the new position of COO, more...

Company and People Notes: EUSA Pharma Makes Deal with GSK, BiPar Sciences Appoints Hoyoung Huh President and CEO, More

To ensure an effective treatment, a patient often must take equal doses of an active pharmaceutical ingredient (API) at regular intervals.

Consistent Capsule Filling

Chesapeake to relocate and expand, AVI BioPharma appoints CEO, More...

Company and People Notes: Chesapeake to Relocate and Expand, AVI BioPharma Appoints CEO, More

Contract manufacturers of active pharmaceutical ingredients and intermediates unveil expansion plans and strategies at this year's Informex.

Informex Roundup

A recent business outlook survey conducted by the Synthetic Organic Chemical Manufacturers Association reveals a generally favorable view of current and future business conditions for contract manufacturing of active pharmaceutical ingredients and intermediates.

Contract Manufacturers Optimistic on Industry Outlook

Amira and GSK Form Agreement, Xenome Appoints Ian Nisbet CEO, More...

Company and People Notes: Amira and GSK Form Agreement, Xenome Appoints Ian Nisbet CEO, More

Contract manufacturers expand capabilities in aseptic processing, clinical-trial materials supply, and cytotoxic manufacturing.

Ingredients